CCP
LABU icon

Carmel Capital Partners’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Carmel Capital Partners’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-500
Closed -$70.7K – 470
2022
Q4 		$70.7K Buy
+500
New +$69.7K 0.05% 128

Other funds holding LABU

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
IMC Chicago
IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AIP
Ahrens Investment Partners Lafayette, Louisiana $202M AUM 3.91% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Carmel Capital Partners's LABU Position: Q1 2023 in Review

Carmel Capital Partners sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q1 2023, closing a stake of 500 shares — an estimated $70.7K sold.

Carmel Capital Partners first reported a position in LABU in Q4 2022 and held it in 1 quarter. The position peaked at $70.7K in Q4 2022. 57 funds tracked by Wall St. Rank hold LABU as of Q1 2023.

  • Carmel Capital Partners reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q1 2023 after selling out during the quarter.
  • Carmel Capital Partners sold 500 Direxion Daily S&P Biotech Bull 3X ETF shares in Q1 2023, an estimated $70.7K.
  • Carmel Capital Partners first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q4 2022 and held it in 1 quarter.
  • Carmel Capital Partners's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $70.7K in Q4 2022.
  • 57 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2023.

Based on Carmel Capital Partners's 13F filing for Q1 2023, filed 19 Apr 2023.